These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 35196944)

  • 1. Circ_0025033 deficiency suppresses paclitaxel resistance and malignant development of paclitaxel-resistant ovarian cancer cells by modulating the miR-532-3p/FOXM1 network.
    Huang H; Yan L; Zhong J; Hong L; Zhang N; Luo X
    Immunopharmacol Immunotoxicol; 2022 Apr; 44(2):275-286. PubMed ID: 35196944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p.
    Liu YY; Zhang LY; Du WZ
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31793989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ_0011292 knockdown mitigates progression and drug resistance in PTX-resistant non-small-cell lung cancer cells by regulating miR-433-3p/CHEK1 axis.
    Jin M; Zhang F; Li Q; Xu R; Liu Y; Zhang Y
    Thorac Cancer; 2022 May; 13(9):1276-1288. PubMed ID: 35348291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ-FOXM1 contributes to cell proliferation, invasion, and glycolysis and represses apoptosis in melanoma by regulating miR-143-3p/FLOT2 axis.
    Tian S; Han G; Lu L; Meng X
    World J Surg Oncol; 2020 Mar; 18(1):56. PubMed ID: 32183822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ_0061140 knockdown inhibits tumorigenesis and improves PTX sensitivity by regulating miR-136/CBX2 axis in ovarian cancer.
    Zhu J; Luo JE; Chen Y; Wu Q
    J Ovarian Res; 2021 Oct; 14(1):136. PubMed ID: 34649611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0,007,331 Promotes the PTX Resistance and Progression of Breast Cancer via miR-200b-3p/ANLN.
    Yang C; Liu L; Gao C; Zhang G; Zhang Y; Zhang S; Li J; Liu Y
    J Surg Res; 2022 Nov; 279():619-632. PubMed ID: 35926312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
    Zang H; Li Y; Zhang X; Huang G
    Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircATL2 enhances paclitaxel resistance of ovarian cancer via impacting miR-506-3p/NFIB axis.
    Ying H; Zhao R; Yu Q; Zhang K; Deng Q
    Drug Dev Res; 2022 Apr; 83(2):512-524. PubMed ID: 34541682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircEXOC6B Suppresses the Proliferation and Motility and Sensitizes Ovarian Cancer Cells to Paclitaxel Through miR-376c-3p/FOXO3 Axis.
    Zheng Y; Li Z; Yang S; Wang Y; Luan Z
    Cancer Biother Radiopharm; 2022 Nov; 37(9):802-814. PubMed ID: 33006481
    [No Abstract]   [Full Text] [Related]  

  • 10. Long non-coding RNA UCA1 promotes the progression of paclitaxel resistance in ovarian cancer by regulating the miR-654-5p/SIK2 axis.
    Li ZY; Wang XL; Dang Y; Zhu XZ; Zhang YH; Cai BX; Zheng L
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):591-603. PubMed ID: 32016960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA circ_0000376 promotes paclitaxel resistance and tumorigenesis of non-small cell lung cancer via positively modulating KPNA4 by sponging miR-1298-5p.
    Hu S; Zhang Q; Sun J; Xue J; Wang C
    Thorac Cancer; 2023 Aug; 14(22):2116-2126. PubMed ID: 37455373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA circ-BNC2 (hsa_circ_0008732) inhibits the progression of ovarian cancer through microRNA-223-3p/ FBXW7 axis.
    Liu T; Yuan L; Zou X
    J Ovarian Res; 2022 Aug; 15(1):95. PubMed ID: 35965327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
    Zhang C; Li Y; Zhao W; Liu G; Yang Q
    Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ_0025033 promotes the progression of ovarian cancer by activating the expression of LSM4 via targeting miR-184.
    Hou W; Zhang Y
    Pathol Res Pract; 2021 Jan; 217():153275. PubMed ID: 33285422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ-PTK2 promotes the proliferation and suppressed the apoptosis of acute myeloid leukemia cells through targeting miR-330-5p/FOXM1 axis.
    Yi L; Zhou L; Luo J; Yang Q
    Blood Cells Mol Dis; 2021 Feb; 86():102506. PubMed ID: 33126007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ-FOXM1 knockdown suppresses non-small cell lung cancer development by regulating the miR-149-5p/ATG5 axis.
    Wei H; Li L; Zhang H; Xu F; Chen L; Che G; Wang Y
    Cell Cycle; 2021 Jan; 20(2):166-178. PubMed ID: 33413028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of circ_CELSR1 facilitates paclitaxel resistance of ovarian cancer by regulating miR-149-5p/SIK2 axis.
    Wei S; Qi L; Wang L
    Anticancer Drugs; 2021 Jun; 32(5):496-507. PubMed ID: 33735118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking circ_0010235 suppresses acquired paclitaxel resistance of non-small cell lung cancer by sponging miR-512-5p to modulate FAM83F expression.
    Li Y; Ma Z; Luo M; Liang R
    Anticancer Drugs; 2022 Nov; 33(10):1024-1034. PubMed ID: 36206095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsa_circ_0004712 downregulation attenuates ovarian cancer malignant development by targeting the miR-331-3p/FZD4 pathway.
    Zhou X; Jiang J; Guo S
    J Ovarian Res; 2021 Sep; 14(1):118. PubMed ID: 34507595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_0067934 reduces JNK phosphorylation through a microRNA-545-3p/PPA1 axis to enhance tumorigenesis and cisplatin resistance in ovarian cancer.
    Yin Y; Li J; Rong J; Zhang B; Wang X; Han H
    Immunopharmacol Immunotoxicol; 2022 Apr; 44(2):261-274. PubMed ID: 35179434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.